M&R Capital Management Inc Scopus Bio Pharma Inc. Transaction History

M&R Capital Management Inc

  • $445 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 04, 2022
BUY
$0.6 - $1.7 $46,091 - $130,592
76,819 New
76,819 $53,000

About Scopus BioPharma Inc.

SCPS Quotes by TradingView
  • Ticker SCPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,094,300
  • Description
  • Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...
More about SCPS
Track This Portfolio

Track M&R Capital Management Inc Portfolio

Follow M&R Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&R Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on M&R Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email